A central goal of the Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical problems that may influence breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient.
LACTATIONAL AMENORRHEA METHOD OF POSTPARTUM CONTRACEPTION

Background and biological basis
Data published in the early 1970s showed that women who breastfed were less likely to ovulate early postpartum, and that if breastfeeding were more intensive, they were less likely than partial or nonbreastfeeders to experience a normal ovulation before the first menstrual-like bleed. 1, 2 In 1988, researchers from several centers around the world met to share their findings at the Rockefeller Bellagio Conference Center, and agreed that three criteria could be sufficient to predict fertility return. These findings were then presented to a group of family planning service providers at Georgetown University, resulting in the codification of the Lactational Amenorrhea Method (LAM) as a family planning method (Fig. 1) . 3 Participants in a second Bellagio meeting held in 1995 brought additional studies that reflected improved knowledge of breastfeeding and fertility, and included studies of the LAM in use. 4 All studies presented confirmed the original findings and demonstrated the potential, efficacy, and usefulness of the LAM. 5 Subsequently, studies continue to support these initial findings. [6] [7] [8] [9] 
Method: what is the LAM?
The LAM is presented as an algorithm (see Fig. 1 ) 3 and includes three criteria for defining the period of lowest pregnancy risk. Furthermore, it advises the immediate commencement of other methods if any one of the three criteria is not met. Clinically, the mother is asked:
• Have you had a menstrual bleed?
• Are you giving any supplementary foods or fluids in addition to breastfeeding? • Is your infant older than 6 months of age?
If she answers negatively to all three criteria, then she meets the requirements for LAM efficacy. She should be advised to initiate another form of contraception if any of the preceding three questions are answered affirmatively to achieve adequate efficacy for birth spacing or fertility limitation. If the mother is interested in, and qualifies for LAM, she is advised to ask herself the same three questions in an ongoing manner. It is advisable to ensure that she has her next method on hand, and initiates its use whenever her answer to any of the three questions changes. She should be advised to contact her health care professional immediately if she has any questions as to whether or not the method still applies.
Definitions for LAM use
To use LAM correctly, it is important that the patient understand each of the three criteria. Menses return, for the purposes of LAM use, is defined as any bleeding that occurs after 56 days postpartum that is perceived by the patient as a menses, or any two consecutive days of bleeding. Full or nearly full breastfeeding is shown in Figure 2 , 10 and includes exclusive, nearly exclusive, and some irregularly provided supplements, as long as they do not disrupt the frequency of feeds. This method of family planning is now used in more than 30 countries and has been included in the family planning and maternal and child health policy in several countries. It has been widely accepted as a natural family planning method that demands no abstinence. It is used as an in- troductory method for the postpartum period, or for the woman who hesitates to use a commodity-based method. It has the added benefit of encouraging optimal breastfeeding behavior, providing synergistic support for primary health of the mother and child.
Efficacy
The LAM has been found to be 98% effective (Fig. 3) 11 and it has been used in a wide variety of settings, including different cultures, socioeconomic groups, and health care venues. Figure 3 illustrates the LAM efficacy in a variety of studies.
The three questions used to ascertain whether the method is in place are in descending order of importance. Amenorrhea is the most important of the three questions, because it alone is associated with a significant reduction in fertility. The intensity of the breastfeeding is also very important because it contributes both to the duration of amenorrhea and the suppression of normal ovulation in the first postpartum cycle, creating the physiologic conditions to ensure that the first bleed will tend to precede the first adequate ovulatory development.
The "6-month" criterion is added primarily because this is when complementary feeding should begin. However, if breastfeeding continues at a high level even after complementary feeding is started, efficacy apparently remains high. In Rwanda, the method was used up to 9 months, maintaining breastfeeding frequency by feeding before each complementary feeding. In a study involving working women, expressing milk after separation at least as often as breastfeeding would occur when together, LAM was found to be 96.5% effective. Although this finding is not statistically different from the results of other studies, it suggests a small increased risk of conception in women separated from their infants. This information should be given to the affected women so that they may make informed decisions.
The World Health Organization (WHO) carried out a prospective trial on lactational amenorrhea and fertility return. Although this was not a study of women selecting and using LAM, the findings confirmed the high efficacy of these LAM trials. 12 A Cochrane literature review on efficacy in 2003 13 was carried out using MEDLINE and EMBASE search from 1966 to 2002, as well as other publications and data sources on lactational amenorrhea. (NB: LAM was not developed and tested as a method until 1990.) Thirteen publications, reporting on nine interventions, and two control groups met the inclusion criteria. The reviewers concluded that LAM is a viable contraceptive method, available and accessible to many women. Life table pregnancy rates at 6 months among LAM users ranged from 0.45% to 2.45%. Life table pregnancy rates of women fully breastfeeding and amenorrheic but not actively using LAM or other contraceptive methods were 0.88% in one study and 0.9% to 1.2% (95% CI 0.0% to 2.4%) in a second study, depending on the definition of menstruation used. The life table menstruation rate at 6 months ranged from 11.1% to 39.4% in these studies and included women who exclusively breastfed for various lengths of time.
Considerations for physician counseling and method use
Postpartum contraception, like breastfeeding, should be discussed with patients during prenatal visits. The contraceptive choice a woman makes, with or without her partner's input, depends on factors such as previous experience with contraceptives, future childbearing plans, husband or partner's attitude, and her lactation status (Table 2) . If a patient is not comfortable with a method, she may use it ineffectively or not at all, even if she does not wish to become pregnant.
There are several common reasons why a woman may choose LAM: She may prefer a period of time without taking medicine or using any devices; she may prefer more time for selection of a long-term or permanent method; or she may wish to try something based on her natural physiology.
Frequent nursing and milk expression alters the hypothalamic pulsatility of gonadotropin releasing hormone (GnRH) production, which in turn mediates follicle stimulating and luteinizing hormones, so that effective ovulation is less likely to occur. Several milk expression studies confirmed that the hormonal response is not identical to breastfeeding, so if the milk expression is a regular occurrence, some of the physiologic responses may be modified. This is not directly mediated by prolactin. A patient who has had a spontaneous or induced abortion prior to 20 weeks usually will have spontaneous ovulation that results in the secretory portion of the menstrual cycle leading to menses. The patient usually will ovulate before any vaginal bleeding. If she delivers at term and is fully breastfeeding, however, vaginal bleeding (once the 6 weeks of lochia has stopped) nearly always occurs prior to first adequate ovulation during the first 6 months. Once regular feeding begins, there is an increase in fertile first cycles. Ovulation in the nonlactating woman may occur as early as 3 weeks postpartum.
LAM management issues
Several suggested behaviors contribute to method success and duration.
• LAM is not meant for patients who are giving regular supplemental feedings.
• Women can use LAM while working if they pump their breasts and provide milk to the baby's caregiver during their absence. However, in one study using this approach, the efficacy was about 95%, slightly lower, but not significantly different than efficacy in women not separated from their infants. Further research is needed on this issue; however, if this is the only method a woman is willing to accept and is well informed of the possibility of decreased efficacy, LAM should remain an option for women who are regularly separated from their infants.
• One set of studies found that exclusively breastfeeding women using LAM are more likely to be amenorrheic at 6 months than exclusively breastfeeding controls (84% versus 69.7%, respectively). Women who use LAM actively have a higher feeding frequency and, hence, shorter interfeeding intervals, than other exclusive breastfeeders (Fig. 4) . However, even with short interfeeding intervals, some women experience earlier menses return. Although it is not known whether these cycles are adequate for conception, no other signs of imminent fertility return are evident. Therefore, whether or not breastfeeding continues to be frequent, another method must be used for birth spacing when menses return.
• Three studies have indicated that the efficacy of LAM can be maintained during the 6-to 12-month period, provided the mother who originally followed this method continues to breastfeed before giving complementary foods at less than 4-hour intervals during the day and 6-hour intervals at night while remaining amenorrheic. 2 
Transition to other methods
When LAM no longer applies, or whenever a breastfeeding woman wishes to use an alternate family planning method, not all other methods have equal consequences for breastfeeding success. Therefore, alternative methods are presented ranked by increasing potential impact on breastfeeding success (Fig. 5) . Although not equally efficacious, the first-choice methods are those that do not interfere with lactation. Although studies show no major problems when progestin-only methods are introduced, the weight of anecdotal evidence, as well as the possible postpartum impact of progestins on prolactin, merits the second choice rating. Estrogen containing pills are known to reduce milk quantity. Optimal child spacing for maternal recovery; the support of lactation duration; and child growth, development, and survival may be influenced by particular demographics. A minimum of 18 months between births is recommended under all circumstances and at least 3 years or longer is recommended in developing countries.
ISSUES IN COUNSELING SELECTION OF CONTRACEPTIVES DURING BREASTFEEDING
Advantages and disadvantages of available options
The issues to be considered in counseling a pregnant or postpartum woman concerning contraceptive choice for use during breastfeeding extend beyond issues of efficacy. She will also wish to ensure that the selected method is appropriate for breastfeeding expectations (as listed in General Principles) in addition to the considerations for the nonlactating woman. Table 3 provides useful information for counseling the lactating mother and is not generally considered in contraception handbooks.
Additional comments on individual methods
Hormonal contraceptive methods. Although Koetsawang 15 reported an increase, Tankeyoon 16 noted a 12% decline in milk supply with progestin-only contraception compared to placebo. A recent Cochrane review indicated that evidence from randomized controlled trials on the effect of hormonal contraceptives 
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during lactation is limited and of poor quality: "Evidence is inadequate to make recommendations regarding hormonal contraceptive use for lactating women." 17 It would be prudent to consider that all hormonal contraceptive methods have some risk of decreasing mother's milk supply. These methods, especially their early use, should be discouraged in several circumstances, as follows:
1. Existing low milk supply or history of lactation failure 2. History of breast surgery 3. Multiple birth (twins, triplets) 4. Preterm birth 5. Compromised health of mother and/or baby If progestin only methods are utilized, the breastfeeding mother may experience dyspareunia secondary to vaginal atrophy that may be alleviated by vaginal lubricants.
Barrier methods. The male condom can provide some protection against sexually transmitted diseases. If a patient has previously used a diaphragm or cervical cap, it should be refitted at the 6-week postpartum visit. As noted, vaginal lubricants may be helpful for breastfeeding patients because vaginal atrophy during lactation may cause dyspareunia.
Intrauterine devices. The intrauterine device (IUD) is one of the most frequently used contraceptives in the world. Various types of IUDs are available (see Appendix). IUD use in the United States had trouble regaining popularity because of the widely publicized litigation resulting from the side-effects of previous IUDs.
